Report Categories
View AllRecent Articles
View All
Why Q32 Bio QTTB might be the portfolio Builder you need 642 20260506
Versamet VMET crushes estimates as EPS shatters forecasts revenue surges 189 YoY yet shares slip 126
ORIC Oric Pharmaceuticals posts narrower than expected Q4 2025 loss shares rise 466 percent in todays trading
ADCT ADC Thera posts far narrower Q4 2025 loss than estimates shares rise modestly after earnings release